The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance.
Saved in:
| Title: | The β-catenin-LINC00183-miR-371b-5p-Smad2/LEF1 axis promotes adult T-cell lymphoblastic lymphoma progression and chemoresistance. |
|---|---|
| Authors: | Huang WJ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.; Biotechnological Institute of Chinese Materia Medical, Jinan University, Guangzhou, China., Guo SB; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Shi H; Department of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.; Biotechnological Institute of Chinese Materia Medical, Jinan University, Guangzhou, China., Li XL; Department of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.; Biotechnological Institute of Chinese Materia Medical, Jinan University, Guangzhou, China., Zhu Y; Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, China.; Anhui Public Health Clinical Center, Hefei, China., Li M; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.; Department of Pathology, Sun Yat-sen University Cancer Center, Guangzhou, China., Song LY; Department of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.; Biotechnological Institute of Chinese Materia Medical, Jinan University, Guangzhou, China., Yu RM; Department of Pharmacology, College of Pharmacy, Jinan University, Guangzhou, China.; Biotechnological Institute of Chinese Materia Medical, Jinan University, Guangzhou, China., Cai QQ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Tian XP; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. tianxp@sysucc.org.cn.; State Key Laboratory of Oncology in South China, Collaborative Innovation Center of Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. tianxp@sysucc.org.cn. |
| Source: | Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2023 Apr 28; Vol. 42 (1), pp. 105. Date of Electronic Publication: 2023 Apr 28. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: BioMed Central Country of Publication: England NLM ID: 8308647 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-9966 (Electronic) Linking ISSN: 03929078 NLM ISO Abbreviation: J Exp Clin Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
